{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:06:23Z","timestamp":1794877583258,"version":"4.9.1"},"reference-count":78,"publisher":"American Association for Cancer Research (AACR)","issue":"16","funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["1DP2CA247830-01"],"award-info":[{"award-number":["1DP2CA247830-01"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000875","name":"Pew Charitable Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA292818"],"award-info":[{"award-number":["R01CA292818"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Regulatory T cells (Treg) infiltrate most tumors, and increased Treg infiltration is correlated with reduced survival in patients with cancer. Although Tregs suppress antitumor immunity, they are also integral for preventing harmful inflammation in nontumor tissues, hindering the development of cancer therapeutic strategies targeting all Tregs systemically. In this study, we used intratumoral (IT) delivery of diphtheria toxin (DT) in Foxp3DTR mice to deplete Tregs within tumor tissues while leaving peripheral Tregs intact. IT delivery of DT reduced Treg frequencies in the tumor, which promoted potent tumor control without autoimmunity. Interestingly, tumor control was principally mediated by CD4+ T cells, whereas CD8+ T cells only contributed when CD4+ T cells were absent. Although conventional dendritic cells (cDC) were required to clear tumors, either type I DCs or type II DCs (cDC2) alone were sufficient to promote tumor control. Distant secondary tumors, mimicking metastases, were also controlled by IT Treg ablation in the primary tumor. Mechanistically, IT Tregs suppressed antitumor T-cell responses by blocking the acquisition and presentation of tumor antigen by cDC2s. Importantly, similar mechanisms of control were observed using a clinically translatable IT Treg-depleting anti-CCR8 antibody. Collectively, these findings reveal a distinct therapeutic strategy that leverages CD4+ T cells upon ablation of Tregs within tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Localized ablation of intratumoral Tregs activates an alternative arm of the immune system by acting on type II conventional dendritic cells and CD4+ T cells, inducing prolonged suppression of tumor growth.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-25-3473","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:03:12Z","timestamp":1780412592000},"page":"4028-4042","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intratumoral Regulatory T-cell Ablation Mediates Tumor Control Systemically without Autoimmunity"],"prefix":"10.1158","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5444-5036","authenticated-orcid":false,"given":"Alissa","family":"Bockman","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an7q238","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California 1 Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, , Berkeley, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3199-9422","authenticated-orcid":false,"given":"Chenyu","family":"Zhang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an7q238","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California 1 Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, , Berkeley, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2457-9515","authenticated-orcid":false,"given":"Brenna","family":"Gittins","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an7q238","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California 1 Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, , Berkeley, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7815-1082","authenticated-orcid":false,"given":"Jessica","family":"Hung","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an7q238","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California 1 Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, , Berkeley, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0384-1548","authenticated-orcid":false,"given":"Timothy F.","family":"Campbell","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an7q238","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California 1 Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, , Berkeley, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7612-6852","authenticated-orcid":false,"given":"Mariela A.","family":"Moreno Ayala","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an7q238","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California 1 Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, , Berkeley, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0788-1767","authenticated-orcid":false,"given":"Doroth\u00e9e","family":"Saddier Axe","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/056546b03","id-type":"ROR","asserted-by":"publisher"}],"name":"Gilead Sciences, Inc. 2 , Foster City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3626-1028","authenticated-orcid":false,"given":"Brian M.","family":"Weist","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/056546b03","id-type":"ROR","asserted-by":"publisher"}],"name":"Gilead Sciences, Inc. 2 , Foster City, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1479-9840","authenticated-orcid":false,"given":"Michel","family":"DuPage","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an7q238","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California 1 Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, , Berkeley, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"2026081403071654500_bib1","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med"},{"key":"2026081403071654500_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejso.2007.08.008","article-title":"Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma","volume":"34","author":"Sasaki","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"2026081403071654500_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lungcan.2011.06.002","article-title":"Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells","volume":"75","author":"Tao","year":"2012","journal-title":"Lung Cancer"},{"key":"2026081403071654500_bib4","doi-asserted-by":"crossref","first-page":"15179","DOI":"10.1038\/srep15179","article-title":"Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis","volume":"5","author":"Shang","year":"2015","journal-title":"Sci Rep"},{"key":"2026081403071654500_bib5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"2026081403071654500_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"},{"key":"2026081403071654500_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ni1428","article-title":"Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice","volume":"8","author":"Kim","year":"2007","journal-title":"Nat Immunol"},{"key":"2026081403071654500_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"2026081403071654500_bib9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"2026081403071654500_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1158\/0008-5472.CAN-18-1250","article-title":"Precise spatiotemporal interruption of regulatory T-cell-mediated CD8+ T-cell suppression leads to tumor immunity","volume":"79","author":"Zhou","year":"2019","journal-title":"Cancer Res"},{"key":"2026081403071654500_bib11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.immuni.2023.01.010","article-title":"Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer","volume":"56","author":"Zagorulya","year":"2023","journal-title":"Immunity"},{"key":"2026081403071654500_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2019.02.005","article-title":"Unleashing type-2 dendritic cells to drive protective antitumor CD4+ T cell immunity","volume":"177","author":"Binnewies","year":"2019","journal-title":"Cell"},{"key":"2026081403071654500_bib13","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1158\/1078-0432.CCR-10-1073","article-title":"Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients","volume":"16","author":"Deng","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2026081403071654500_bib14","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/s41467-020-17046-2","article-title":"Tumor invasion in draining lymph nodes is associated with treg accumulation in breast cancer patients","volume":"11","author":"N\u00fa\u00f1ez","year":"2020","journal-title":"Nat Commun"},{"key":"2026081403071654500_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/imm.13058","article-title":"Treg programming and therapeutic reprogramming in cancer","volume":"157","author":"Moreno Ayala","year":"2019","journal-title":"Immunology"},{"key":"2026081403071654500_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/2326-6066.CIR-13-0013","article-title":"Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells","volume":"1","author":"Selby","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"2026081403071654500_bib17","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1084\/jem.20130579","article-title":"Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma","volume":"210","author":"Simpson","year":"2013","journal-title":"J Exp Med"},{"key":"2026081403071654500_bib18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1084\/jem.20071341","article-title":"OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection","volume":"205","author":"Piconese","year":"2008","journal-title":"J Exp Med"},{"key":"2026081403071654500_bib19","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026081403071654500_bib20","doi-asserted-by":"crossref","first-page":"e2300895120","DOI":"10.1073\/pnas.2300895120","article-title":"Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies","volume":"120","author":"Lax","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026081403071654500_bib21","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1038\/s41598-022-09458-5","article-title":"The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer","volume":"12","author":"Haruna","year":"2022","journal-title":"Sci Rep"},{"key":"2026081403071654500_bib22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/imm.13337","article-title":"CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function","volume":"163","author":"Whiteside","year":"2021","journal-title":"Immunology"},{"key":"2026081403071654500_bib23","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.immuni.2016.10.021","article-title":"Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells. Immunity","volume":"45","author":"De Simone","year":"2016","journal-title":"Immunity"},{"key":"2026081403071654500_bib24","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.immuni.2016.10.032","article-title":"Regulatory T cells exhibit distinct features in human breast cancer","volume":"45","author":"Plitas","year":"2016","journal-title":"Immunity"},{"key":"2026081403071654500_bib25","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1158\/0008-5472.CAN-18-1119","article-title":"Targeting CCR8 induces protective antitumor immunity and enhances vaccine-induced responses in Colon cancer","volume":"78","author":"Villarreal","year":"2018","journal-title":"Cancer Res"},{"key":"2026081403071654500_bib26","doi-asserted-by":"crossref","first-page":"e001749","DOI":"10.1136\/jitc-2020-001749","article-title":"Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy","volume":"9","author":"Van Damme","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026081403071654500_bib27","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1158\/0008-5472.CAN-20-3585","article-title":"Fc-optimized anti-CCR8 antibody depletes regulatory T cells in human tumor models","volume":"81","author":"Campbell","year":"2021","journal-title":"Cancer Res"},{"key":"2026081403071654500_bib28","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00262-020-02583-y","article-title":"CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer","volume":"69","author":"Wang","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"2026081403071654500_bib29","doi-asserted-by":"crossref","first-page":"2141007","DOI":"10.1080\/2162402X.2022.2141007","article-title":"Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody","volume":"11","author":"Weaver","year":"2022","journal-title":"Oncoimmunology"},{"key":"2026081403071654500_bib30","doi-asserted-by":"crossref","first-page":"e2114282119","DOI":"10.1073\/pnas.2114282119","article-title":"CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory","volume":"119","author":"Kidani","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026081403071654500_bib31","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1158\/1078-0432.CCR-10-1757","article-title":"Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I\/II study in metastatic melanoma patients","volume":"16","author":"Jacobs","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2026081403071654500_bib32","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1158\/1078-0432.CCR-19-1090","article-title":"A phase I study of the anti-CC chemokine receptor 4 antibody, mogamulizumab, in combination with nivolumab in patients with advanced or metastatic solid tumors","volume":"25","author":"Doi","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2026081403071654500_bib33","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1158\/1078-0432.CCR-18-0762","article-title":"Anti-CTLA-4 immunotherapy does not deplete FOXP3+ regulatory T cells (tregs) in human cancers","volume":"25","author":"Sharma","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2026081403071654500_bib34","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20130573","article-title":"Activating Fc \u03b3 receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies","volume":"210","author":"Bulliard","year":"2013","journal-title":"J Exp Med"},{"key":"2026081403071654500_bib35","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s43018-022-00447-1","article-title":"Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through Fc\u03b3R engagement and type I interferon signaling","volume":"3","author":"Yofe","year":"2022","journal-title":"Nat Cancer"},{"key":"2026081403071654500_bib36","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ccell.2016.05.001","article-title":"Therapeutic activity of agonistic, human anti-CD40 monoclonal antibodies requires selective Fc\u03b3R engagement","volume":"29","author":"Dahan","year":"2016","journal-title":"Cancer Cell"},{"key":"2026081403071654500_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4049\/jimmunol.2200950","article-title":"Targeted TLR9 agonist elicits effective antitumor immunity against spontaneously arising breast tumors","volume":"211","author":"Miller","year":"2023","journal-title":"J Immunol"},{"key":"2026081403071654500_bib38","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1158\/0008-5472.CAN-21-1382","article-title":"Neoadjuvant intratumoral immunotherapy with TLR9 activation and anti-OX40 antibody eradicates metastatic cancer","volume":"82","author":"Hong","year":"2022","journal-title":"Cancer Res"},{"key":"2026081403071654500_bib39","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1172\/JCI64859","article-title":"Depleting tumor-specific tregs at a single site eradicates disseminated tumors","volume":"123","author":"Marabelle","year":"2013","journal-title":"J Clin Invest"},{"key":"2026081403071654500_bib40","doi-asserted-by":"crossref","first-page":"eabn5859","DOI":"10.1126\/sciimmunol.abn5859","article-title":"Intratumoral immunotherapy relies on B and T cell collaboration","volume":"7","author":"Sagiv-Barfi","year":"2022","journal-title":"Sci Immunol"},{"key":"2026081403071654500_bib41","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1158\/1078-0432.CCR-19-3642","article-title":"Intratumoral immunotherapy for early-stage solid tumors","volume":"26","author":"Hong","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2026081403071654500_bib42","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1084\/jem.20130762","article-title":"Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy","volume":"210","author":"Bos","year":"2013","journal-title":"J Exp Med"},{"key":"2026081403071654500_bib43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.20160062","article-title":"Absence of MHC class II on cDCs results in microbial-dependent intestinal inflammation","volume":"213","author":"Loschko","year":"2016","journal-title":"J Exp Med"},{"key":"2026081403071654500_bib44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41586-022-04866-z","article-title":"Ablation of cDC2 development by triple mutations within the Zeb2 enhancer","volume":"607","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"2026081403071654500_bib45","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"2026081403071654500_bib46","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1158\/0008-5472.CAN-13-3065","article-title":"Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer","volume":"74","author":"Pastille","year":"2014","journal-title":"Cancer Res"},{"key":"2026081403071654500_bib47","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1158\/0008-5472.CAN-09-1574","article-title":"Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion","volume":"70","author":"Teng","year":"2010","journal-title":"Cancer Res"},{"key":"2026081403071654500_bib48","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.163.10.5211","article-title":"Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity","volume":"163","author":"Shimizu","year":"1999","journal-title":"J Immunol"},{"key":"2026081403071654500_bib49","doi-asserted-by":"crossref","first-page":"101469","DOI":"10.1016\/j.tranon.2022.101469","article-title":"Tumour-draining lymph nodes in head and neck cancer are characterized by accumulation of CTLA-4 and PD-1 expressing Treg cells","volume":"23","author":"Piersiala","year":"2022","journal-title":"Transl Oncol"},{"key":"2026081403071654500_bib50","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nm1602","article-title":"A spatially and temporally restricted mouse model of soft tissue sarcoma","volume":"13","author":"Kirsch","year":"2007","journal-title":"Nat Med"},{"key":"2026081403071654500_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature10803","article-title":"Expression of tumour-specific antigens underlies cancer immunoediting","volume":"482","author":"DuPage","year":"2012","journal-title":"Nature"},{"key":"2026081403071654500_bib52","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.immuni.2015.08.006","article-title":"Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses","volume":"43","author":"Joshi","year":"2015","journal-title":"Immunity"},{"key":"2026081403071654500_bib53","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1158\/1078-0432.CCR-12-0781","article-title":"Controlled local delivery of CTLA-4 blocking antibody induces CD8+ T-cell-dependent tumor eradication and decreases risk of toxic side effects","volume":"19","author":"Fransen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2026081403071654500_bib54","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ccell.2024.05.013","article-title":"Interruption of the intratumor CD8+ T cell:treg crosstalk improves the efficacy of PD-1 immunotherapy","volume":"42","author":"Geels","year":"2024","journal-title":"Cancer Cell"},{"key":"2026081403071654500_bib55","doi-asserted-by":"crossref","first-page":"eade2094","DOI":"10.1126\/sciimmunol.ade2094","article-title":"Intratumoral antigen signaling traps CD8+ T cells to confine exhaustion to the tumor site","volume":"9","author":"Takahashi","year":"2024","journal-title":"Sci Immunol"},{"key":"2026081403071654500_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.immuni.2019.12.007","article-title":"Regulatory T cells restrain interleukin-2- and Blimp-1-dependent acquisition of cytotoxic function by CD4+ T cells","volume":"52","author":"\u015aledzi\u0144ska","year":"2020","journal-title":"Immunity"},{"key":"2026081403071654500_bib57","doi-asserted-by":"crossref","first-page":"eadx4411","DOI":"10.1126\/sciimmunol.adx4411","article-title":"Intratumoral Treg cell ablation elicits NK cell-mediated control of CD8 T cell-resistant tumors","volume":"11","author":"Zhang","year":"2026","journal-title":"Sci Immunol"},{"key":"2026081403071654500_bib58","doi-asserted-by":"crossref","first-page":"e180080","DOI":"10.1172\/JCI180080","article-title":"Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy","volume":"134","author":"Zhou","year":"2024","journal-title":"J Clin Invest"},{"key":"2026081403071654500_bib59","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1084\/jem.20112675","article-title":"Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage","volume":"209","author":"Meredith","year":"2012","journal-title":"J Exp Med"},{"key":"2026081403071654500_bib60","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20120030","article-title":"Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages","volume":"209","author":"Satpathy","year":"2012","journal-title":"J Exp Med"},{"key":"2026081403071654500_bib61","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","article-title":"CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity","volume":"56","author":"Moreno Ayala","year":"2023","journal-title":"Immunity"},{"key":"2026081403071654500_bib62","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","article-title":"Dendritic cells as shepherds of T cell immunity in cancer","volume":"56","author":"Pittet","year":"2023","journal-title":"Immunity"},{"key":"2026081403071654500_bib63","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"2026081403071654500_bib64","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"2026081403071654500_bib65","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","article-title":"Interferon-\u03b3 drives Treg fragility to promote anti-tumor immunity","volume":"169","author":"Overacre-Delgoffe","year":"2017","journal-title":"Cell"},{"key":"2026081403071654500_bib66","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"2026081403071654500_bib67","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ccell.2014.11.010","article-title":"Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity","volume":"26","author":"Broz","year":"2014","journal-title":"Cancer Cell"},{"key":"2026081403071654500_bib68","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity"},{"key":"2026081403071654500_bib69","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-020-2134-y","article-title":"A conserved dendritic-cell regulatory program limits antitumour immunity","volume":"580","author":"Maier","year":"2020","journal-title":"Nature"},{"key":"2026081403071654500_bib70","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.ccell.2024.06.014","article-title":"Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity","volume":"42","author":"You","year":"2024","journal-title":"Cancer Cell"},{"key":"2026081403071654500_bib71","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s43018-025-00935-0","article-title":"Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss","volume":"6","author":"Xiao","year":"2025","journal-title":"Nat Cancer"},{"key":"2026081403071654500_bib72","doi-asserted-by":"crossref","first-page":"e2105323118","DOI":"10.1073\/pnas.2105323118","article-title":"Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy","volume":"118","author":"Ho","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026081403071654500_bib73","doi-asserted-by":"crossref","first-page":"101052","DOI":"10.1016\/j.xcrm.2023.101052","article-title":"Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy","volume":"4","author":"Budhu","year":"2023","journal-title":"Cell Rep Med"},{"key":"2026081403071654500_bib74","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ccell.2020.02.008","article-title":"Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer","volume":"37","author":"Hegde","year":"2020","journal-title":"Cancer Cell"},{"key":"2026081403071654500_bib75","doi-asserted-by":"crossref","first-page":"844866","DOI":"10.3389\/fimmu.2022.844866","article-title":"Mechanisms of MHC-I downregulation and role in immunotherapy response","volume":"13","author":"Taylor","year":"2022","journal-title":"Front Immunol"},{"key":"2026081403071654500_bib76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"2026081403071654500_bib77","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.immuni.2022.09.015","article-title":"Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing","volume":"55","author":"MacNabb","year":"2022","journal-title":"Immunity"},{"key":"2026081403071654500_bib78","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","article-title":"Allele-specific HLA loss and immune escape in lung cancer evolution","volume":"171","author":"McGranahan","year":"2017","journal-title":"Cell"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-25-3473\/3800565\/can-25-3473.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-25-3473\/3814582\/can-25-3473.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/16\/4028\/3819297\/can-25-3473.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/16\/4028\/3819297\/can-25-3473.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:07:31Z","timestamp":1786691251000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/86\/16\/4028\/787289\/Intratumoral-Regulatory-T-cell-Ablation-Mediates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":78,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,6,2]]},"published-print":{"date-parts":[[2026,8,14]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-25-3473","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.33252885","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33252894","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33252882","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33252888","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33252897","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33252879","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33252891","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.8653755","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]}}}